PLA2G4C was downregulated in the tested TNBC cell lines (Additional file 1: Fig. S2A), and higher PLA2G4C mRNA levels correlated with longer survival in breast cancer patients (Additional file 1: Fig. S2C). This evidence concerns the gene PLA2G4C and breast carcinoma.